Bayer Revenue 2010-2021 | BAYRY

Bayer annual/quarterly revenue history and growth rate from 2010 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Bayer revenue for the quarter ending December 31, 2021 was $12.678B, a 4.72% increase year-over-year.
  • Bayer revenue for the twelve months ending December 31, 2021 was $52.152B, a 10.28% increase year-over-year.
  • Bayer annual revenue for 2021 was $52.152B, a 10.28% increase from 2020.
  • Bayer annual revenue for 2020 was $47.291B, a 3.03% decline from 2019.
  • Bayer annual revenue for 2019 was $48.77B, a 4.32% increase from 2018.
Bayer Annual Revenue
(Millions of US $)
2021 $52,152
2020 $47,291
2019 $48,770
2018 $46,751
2017 $39,577
2016 $51,755
2015 $51,438
2014 $56,148
2013 $53,341
2012 $51,135
2011 $50,876
2010 $46,593
2009 $43,467
Bayer Quarterly Revenue
(Millions of US $)
2021-12-31 $12,678
2021-09-30 $11,534
2021-06-30 $13,078
2021-03-31 $14,863
2020-12-31 $12,107
2020-09-30 $9,944
2020-06-30 $11,070
2020-03-31 $14,171
2019-12-31 $10,148
2019-09-30 $10,931
2019-06-30 $12,909
2019-03-31 $14,782
2018-12-31 $12,695
2018-09-30 $11,517
2018-06-30 $11,307
2018-03-31 $11,232
2017-12-31 $4,102
2017-09-30 $9,432
2017-06-30 $13,411
2017-03-31 $12,633
2016-12-31 $12,646
2016-09-30 $12,568
2016-06-30 $13,367
2016-03-31 $13,173
2015-12-31 $12,109
2015-09-30 $12,279
2015-06-30 $13,374
2015-03-31 $13,676
2014-12-31 $13,819
2014-09-30 $13,517
2014-06-30 $14,346
2014-03-31 $14,466
2013-12-31 $13,477
2013-09-30 $12,774
2013-06-30 $13,529
2013-03-31 $13,560
2012-12-31 $12,779
2012-09-30 $12,095
2012-06-30 $13,078
2012-03-31 $13,183
2011-12-31 $12,366
2011-09-30 $12,277
2011-06-30 $13,314
2011-03-31 $12,870
2010-12-31 $12,390
2010-09-30 $11,069
2010-06-30 $11,712
2010-03-31 $10,969
2009-12-31 $11,282
2009-09-30 $11,087
2009-06-30 $10,908
2009-03-31 $10,327
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $63.150B $52.156B
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $465.363B 17.90
Pfizer (PFE) United States $280.096B 9.77
Eli Lilly (LLY) United States $277.095B 32.69
AbbVie (ABBV) United States $271.251B 11.89
Merck (MRK) United States $228.629B 12.92
Novartis AG (NVS) Switzerland $191.957B 13.82
GlaxoSmithKline (GSK) United Kingdom $110.111B 12.85
Novo Nordisk (NVO) Denmark $0.000B 31.56